Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 43
- Uncategorized
CRS Research Says Cannabis Rescheduling Future ‘Unclear’ as Legal Challenges Emerge
This week has seen another frenetic torrent of executive orders issued by the newly inaugurated President Trump, causing chaos across almost all of America’s cornerstone institutions.
- Data & Analysis
Australia’s Medical Cannabis Market Set to Outgrow Europe’s Biggest Players
According to Prohibition Partners’ new Global Cannabis Report: 5th Edition, launching today, Australia’s medical cannabis revenues are expected to grow from around US$600m in 2024 to more than US$1.2bn by 2028.
- Uncategorized
Missouri Considers Classing All Intoxicating Hemp as Cannabis
Missouri lawmakers are grappling with the regulation of hemp-derived intoxicating products, as the Senate hears testimony on the Intoxicating Cannabinoid Control Act (Senate Bill 54, SB54).
- Uncategorized
Poll Shows 96% of Cannabis Consumers Distrust DEA’s Role in Rescheduling Debate
Two weeks after the shock suspension of proceedings in the landmark cannabis rescheduling process, it appears the US public believes it was the correct choice.
- Medical
Will Germany’s Medical Cannabis Boom Survive the February Election?
A month out from Germany’s federal election, alarm bells are ringing for the booming cannabis market.
- Uncategorized
Wird Deutschlands medizinischer Cannabis-Boom die Wahlen im Februar überleben?
Einen Monat vor der Bundestagswahl in Deutschland läuten die Alarmglocken für den boomenden Cannabismarkt.
- Uncategorized
New York Judge Bans Warrantless Searches of Cannabis Stores
The New York State Supreme Court has banned police and the state regulator from conducting warrantless searches of licensed hemp retailers.
- Data & Analysis
Canadian Medical Cannabis Exports Doubled in First 6 Months of 2024
Canadian medical cannabis exports expanded dramatically in 2024 amid the rapid expansion of markets across Europe.
- Markets & Stocks
Celadon’s Shares Spike as Partnership Starts Generating Revenue, Phillip Morris Expands Cannabis Footprint, & More from DanCann Pharma
Celadon Pharmaceuticals [stock_market_widget type=”chart” template=”line” assets=”CEL.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Celadon Pharmaceuticals has seen its stock price spike this week after revealing that its supply agreement with Danish firm Valeos is now ‘actively contributing to Celadon’s operations.’
- Uncategorized
Cannabis Rescheduling Feared ‘Dead’ Following Appointment of New DEA Administrator Maltz
Cannabis rescheduling was dealt a major blow today as it was confirmed that long-time cannabis sceptic and anti-drug veteran Derek S. Maltz has been appointed as acting administrator of the DEA.
- CBD Market
Poland Eyes CBD Ban as its Medical Cannabis Crackdown Sees Prescription Numbers Plummet
Poland has seen the number of medical cannabis prescriptions plummet since it moved to crack down on telemedicine prescriptions.
- Hemp Industry
Czech Republic Pushes Ahead With Pioneering ‘Psychomodulating Substances’ Regulation
The Czech Republic is continuing to make progress on an ambitious overhaul of its drug policies, with sweeping reforms aimed at creating a regulated market for low-risk psychoactive substances and addressing long-standing issues in medical cannabis access.











